Richard K. Murray, MD
Vice President
External Medical & Scientific Affairs
Merck & Co., Inc.

As Vice President of External Medical & Scientific Affairs at Merck & Co., Inc., Dr. Richard K. Murray is responsible for overseeing a broad set of external interactions between Merck medical and scientific personnel and physician leaders, investigators, leaders in managed care, and other aspects of health care within the US.  External interactions involving scientific and medical information, research collaborations related to health services and quality, strategic alliances with professional organizations, and support for independent education are all important activities managed by EMSA. 

Dr. Murray, a native Washingtonian, graduated from Howard University College of Medicine in Washington DC and subsequently was an Intern, Medical Resident, Chief Medical Resident and a Pulmonary & Critical Care Fellow at the University of Pennsylvania in Philadelphia.  Prior to joining Merck, Dr. Murray was Assistant Professor of Medicine at the University of Pennsylvania where he was an investigator in the area of reactive airways disease, smooth muscle function and calcium signaling.  He was also Co-Director of the Adult Asthma Program at the Hospital of the University of Pennsylvania.

Dr. Murray joined Merck & Co., Inc. in November 1994, where he was a founding member of the Regional Medical Director Program at Merck.  Over the subsequent 10 years, he has assumed increasing responsibility within the US Human Health Medical and Scientific Affairs area, and was promoted to Vice President, External Medical & Scientific Affairs in August of 2007.

Dr. Murray is Board Certified in Internal Medicine and Pulmonary Diseases.  He is a Fellow of the American College of Physicians, a Fellow of the American College of Chest Physicians and a Fellow of the College of Physicians of Philadelphia.  He served on the Board of Directors for the Merck Institute of Aging and Health and serves on the Board of Directors for the Merck Childhood Asthma Network.  He represented Merck as a member of the Clinical Research Roundtable at the Institute of Medicine in 2004.